|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:acquisition
|
gptkb:Celgene_Corporation
gptkb:Immunomedics
gptkb:Juno_Therapeutics
gptkb:Myokardia
gptkb:Celgene
gptkb:Celerion
Acquisition of Celgene
|
|
gptkbp:acquisition_year
|
gptkb:2019
gptkb:2020
gptkb:2021
gptkb:2022
gptkb:2023
|
|
gptkbp:ceo
|
gptkb:Giovanni_Caforio
|
|
gptkbp:clinical_trial
|
gptkb:Phase_4
global
Phase 1
Phase 2
Phase 3
Phase 3 trials
collaborative
Phase 1 trials
Phase 2 trials
patient-centric
|
|
gptkbp:conducts_research_on
|
gptkb:Thomas_C._Südhof
|
|
gptkbp:employees
|
30,000+
|
|
gptkbp:focus
|
Biopharmaceuticals
|
|
gptkbp:focus_area
|
gptkb:Oncology
Immunology
Cardiovascular
Fibrosis
|
|
gptkbp:founded
|
1887
|
|
gptkbp:founder
|
gptkb:John_Myers
gptkb:William_Mc_Laren_Bristol
|
|
gptkbp:headcount
|
30,000+
|
|
gptkbp:headquarters
|
gptkb:New_York_City,_New_York
gptkb:New_York
gptkb:New_York_City
gptkb:United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bristol-Myers Squibb
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
|
gptkbp:market_cap
|
$150 billion (2021)
$160 billion (2022)
$170 billion (2023)
|
|
gptkbp:number_of_employees
|
30,000+
|
|
gptkbp:partnership
|
gptkb:Iovance_Biotherapeutics
gptkb:Astra_Zeneca
gptkb:Pfizer
gptkb:Abb_Vie
gptkb:Nant_Kwest
|
|
gptkbp:philanthropy
|
gptkb:education
gptkb:healthcare_access
gptkb:Bristol-Myers_Squibb_Foundation
community support
education initiatives
disaster relief
community health
|
|
gptkbp:product
|
gptkb:Opdivo
|
|
gptkbp:products
|
gptkb:Opdivo
gptkb:Eliquis
gptkb:Yervoy
|
|
gptkbp:research_and_development
|
gptkb:Rupert_Vessey
$7 billion (2020)
|
|
gptkbp:research_areas
|
oncology
fibrosis
immunology
cardiovascular
|
|
gptkbp:research_focus
|
gptkb:gene_therapy
gptkb:Cell
oncology
cardiovascular diseases
biologics
immunology
small molecules
cancer immunotherapy
|
|
gptkbp:revenue
|
$46.4 billion (2020)
|
|
gptkbp:stock_exchange
|
gptkb:New_York_Stock_Exchange
|
|
gptkbp:stock_symbol
|
BMY
|
|
gptkbp:subsidiary
|
gptkb:Celgene_Corporation
gptkb:Zymeworks
gptkb:Juno_Therapeutics
gptkb:Myokardia
gptkb:Bristol-Myers_Squibb_Foundation
gptkb:Celgene
gptkb:Nant_Kwest
Myocardia
|
|
gptkbp:sustainability
|
gptkb:supply_chain_management
energy efficiency
waste reduction
green chemistry
environmental responsibility
|
|
gptkbp:sustainability_initiatives
|
community engagement
diversity and inclusion
employee engagement
environmental responsibility
supply chain responsibility
|
|
gptkbp:traded_on
|
gptkb:NYSE
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
www.bms.com
|
|
gptkbp:bfsParent
|
gptkb:biotechnology
gptkb:W3_C
gptkb:Bill_Gates
|
|
gptkbp:bfsLayer
|
3
|